Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and adult toys.
Popular Articles

Lowell Elementary Closes Due To High Rate Of Influenza Like Illness
Today, the Maricopa County Department of Public Health in cooperation with Phoenix Elementary School District has closed Lowell Elementary School until May 26, 2009 due to a high rate of influenza like illness.
buy viagra
Two Studies Report Finding New Genes And Gene Regions That Make People Susceptible To MS
Two studies recently published in the journal Nature Genetics report identifying new genes and gene regions that contribute to making people susceptible to developing MS. The findings, by the International Multiple Sclerosis Genetics Consortium and the Australia/New Zealand MS Genetics Consortium, add to a growing list of gene variations linked to MS susceptibility. Identifying all MS genes will likely lead to the development of more effective ways to treat the disease, and open the door to uncovering the cause of MS, which may lead to its prevention.
News of the day
GE Healthcare's Online Sepsis Education Program Stresses Early Recognition And Care
GE Healthcare"s Trends in Sepsis Management online program - based on the six-year Surviving Sepsis Campaign - is designed to engage clinicians in real-life situations involving the identification and treatment of sepsis. Sepsis is the body"s response to infection, which, in more severe forms, can lead to potentially deadly systemic blood vessel inflammation and clotting, organ shutdown and cardiovascular system failure. The rate of severe sepsis cases is expected to rise to one million cases per year by 2010, as the average age of the population increases, the SSC predicts.
Public Health

Breakthrough Breast Cancer's Comment On New Targeted Antibody Therapy For Advanced Her2-Positive Breast Cancer

Dr Alexis Willett, Head of Policy & Involvement at Breakthrough Breast Cancer, says: "This study suggests that patients with HER2 positive advanced breast cancer who are no longer responding to Herceptin or chemotherapy may benefit from the combined Herceptin and DM1 treatment. Whilst many patients responded to the treatment in this trial, further larger studies will be needed to assess the full benefits. "There are limited treatments available for those with advanced breast cancer so improving the range of options is always welcome and we look forward to the results of the ongoing trials of this treatment." Breakthrough Breast Cancer


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009